Certificates & Accreditations
Our treatments are backed by internationally recognized certifications and regulatory approvals, ensuring the highest standards of quality and safety.
Our Partner: ONKIM Stem Cell Technologies
ONKIM is the most efficient and reliable stem cell storage and production center in Turkey. Following the latest technological and scientific developments, ONKIM adds new and updated services to its portfolio and conducts R&D projects with national and international organizations.
International Standards & Certifications
All our partner facilities maintain strict compliance with international regulatory standards and hold multiple certifications from Turkish and international health authorities.
GMP Certificate
Good Manufacturing Practice (GMP) certification ensures our production processes meet the highest international pharmaceutical standards for quality and consistency.
Cord Blood Studies Approval
Official approval from Turkish health authorities for conducting cord blood collection, processing, and research studies.
Umbilical Cord Banking License
Licensed facility for the collection, processing, and long-term storage of umbilical cord blood and tissue for therapeutic applications.
Production Center License
Official license authorizing the production of cell-based therapeutic products in compliance with Turkish Ministry of Health regulations.
Exosome Production Center License
Specialized license for the production of exosome-based therapies, a cutting-edge advancement in regenerative medicine.
The Standards Behind Every Treatment
Regenerative medicine is only as safe as the laboratory, the licensing, and the documentation behind it. Every StemCell Longevita patient is treated under the following regulatory and quality framework.
Turkish Ministry of Health Licensed
Our partner laboratory and treatment protocols are authorized under the Republic of Türkiye Ministry of Health regulatory framework governing advanced cellular therapies. Every procedure is performed in a licensed medical facility under qualified physician supervision.
GMP-Compliant Cell Processing
Wharton's jelly–derived mesenchymal stem cells (MSCs) are prepared in a Good Manufacturing Practice (GMP) certified clean-room laboratory with documented batch-release criteria and full chain-of-custody for every cell product.
ISO 9001 Quality Management System
Quality management is certified to ISO 9001. Every patient pathway — from intake and diagnostics through treatment and follow-up — follows a documented, audited process.
Declaration of Helsinki Compliance
Umbilical cord tissue is sourced exclusively from full-term, consented C-section donations, following Turkish bioethics regulations and the international Declaration of Helsinki standards for ethical medical research and practice.
KVKK & GDPR Data Protection
All patient data is handled in compliance with Turkey's KVKK (Personal Data Protection Law) and the EU General Data Protection Regulation (GDPR), with secure multilingual coordination and structured post-treatment follow-up at 1, 3, 6, and 12 months.
Batch Release & Quality Control
Every cell batch undergoes rigorous quality-control testing — including cell viability counts, sterility testing, endotoxin screening, mycoplasma testing, and surface-marker identity verification — before it is cleared for clinical use. Documentation, batch-release certificates, and licensing references are available on request during your consultation.
15+
Years of Experience
6
Active Certifications
100%
Regulatory Compliance
International Patient Coordination
StemCell Longevita operates as an international patient coordination platform. We connect patients with licensed medical institutions that provide regenerative medicine applications following physician evaluation and applicable regulatory frameworks. All medical decisions and procedures are conducted exclusively by authorized healthcare professionals. StemCell Longevita does not directly provide medical treatment.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Stem cell therapy is an evolving field, and outcomes may vary by individual. The treatments described on this site have not been fully evaluated or approved by the FDA or equivalent regulatory bodies in all jurisdictions.
The FDA has not approved stem cell applications for most conditions listed on this website. Results mentioned are based on clinical observations, published research, and patient-reported outcomes. Individual results may vary and no specific outcomes are assured for any individual patient.
Inclusion of scientific publications on this website does not imply regulatory approval, and does not imply any clinical outcome for an individual patient. Certain applications may be considered investigational depending on indication and jurisdiction.
Always consult with a qualified healthcare professional before making any medical decisions. Do not disregard professional medical advice or delay seeking treatment based on information found on this website.
Related clinical questions
Where this page sits in the wider picture.